Injective (INJ) experienced a 5% increase on Thursday, following an 11.50% gain the day before due to the positive impact of the Testnet going live.
The surge in Open Interest reached a 30-day high of 170 million USD, reflecting heightened optimism in the market regarding Injective and its developments in the DeFi sector.
Technical indicators show bullish momentum, suggesting possible price targets at the 200-day EMA and Fibonacci retracement levels, with significant interest in tokenized stocks.
Leave a Reply